NEWARK, CA / ACCESSWIRE / November 21, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced the selection of PN-881, a potential best-in-class oral peptide ...
AJMC: In your experience, how has the rise of biologic agents in plaque psoriasis really changed the treatment landscape? LEBWOHL: The rise of biologic agents in plaque psoriasis treatment has ...
The family of interleukin-17 (IL-17) includes six molecules that respond to infection, in addition to participating in various physiological and pathological processes. A new paper in Signal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results